{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:34:33Z","timestamp":1772102073237,"version":"3.50.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["RD16\/0008"],"award-info":[{"award-number":["RD16\/0008"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00808","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T04:11:55Z","timestamp":1524111115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration"],"prefix":"10.3389","volume":"9","author":[{"given":"Blanca","family":"Molins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Romero-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Fuentes-Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Adan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0002-9394(04)00052-2","article-title":"The epidemiology of age-related macular degeneration","volume":"137","author":"Klein","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1023\/A:1025643303914","article-title":"Epidemiology of age-related maculopathy: a review","volume":"18","author":"van Leeuwen","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","article-title":"Prevalence of age-related macular degeneration in the US population","volume":"129","author":"Klein","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"FASEB J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"348092","DOI":"10.1155\/2013\/348092","article-title":"The role of the immune response in age-related macular degeneration","volume":"2013","author":"Whitcup","year":"2013","journal-title":"Int J Inflam"},{"key":"B11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1242\/dmm.012559","article-title":"Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models","volume":"6","author":"Demontis","year":"2013","journal-title":"Dis Model Mech"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bjo.2005.073643","article-title":"Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation","volume":"90","author":"Khan","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jama.1996.03540140035023","article-title":"A prospective study of cigarette smoking and risk of age-related macular degeneration in men","volume":"276","author":"Christen","year":"1996","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.1996.03540140029022","article-title":"A prospective study of cigarette smoking and age-related macular degeneration in women","volume":"276","author":"Seddon","year":"1996","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","article-title":"Risk factors for incident age-related macular degeneration: pooled findings from 3 continents","volume":"111","author":"Tomany","year":"2004","journal-title":"Ophthalmology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.291.6.704","article-title":"Association between C-reactive protein and age-related macular degeneration","volume":"291","author":"Seddon","year":"2004","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/archopht.125.5.671","article-title":"The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report no. 20","volume":"125","author":"SanGiovanni","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"B24","first-page":"32","article-title":"Oxidative damage and age-related macular degeneration","volume":"5","author":"Winkler","year":"1999","journal-title":"Mol Vis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.ophtha.2005.07.004","article-title":"Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration","volume":"112","author":"Vine","year":"2005","journal-title":"Ophthalmology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archophthalmol.2010.355","article-title":"Diabetes mellitus and early age-related macular degeneration","volume":"129","author":"Choi","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ophtha.2006.09.033","article-title":"Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study","volume":"114","author":"Tan","year":"2007","journal-title":"Ophthalmology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2012.10.018","article-title":"Age-related macular degeneration revisited \u2013 piecing the puzzle: the LXIX Edward Jackson memorial lecture","volume":"155","author":"Miller","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajo.2014.03.014","article-title":"Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention","volume":"158","author":"Nussenblatt","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration","volume":"122","author":"Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"17456","DOI":"10.1073\/pnas.0606234103","article-title":"Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid","volume":"103","author":"Johnson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","article-title":"The role of inflammation in the pathogenesis of age-related macular degeneration","volume":"51","author":"Donoso","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/eye.2016.177","article-title":"Doyne lecture 2016: intraocular health and the many faces of inflammation","volume":"31","author":"Dick","year":"2017","journal-title":"Eye (Lond)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1073\/pnas.1403814111","article-title":"DICER1\/Alu RNA dysmetabolism induces caspase-8-mediated cell death in age-related macular degeneration","volume":"111","author":"Kim","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye","volume":"134","author":"Anderson","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1167\/iovs.07-1072","article-title":"Complement-associated deposits in the human retina","volume":"49","author":"Seth","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1167\/iovs.10-5322","article-title":"Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells","volume":"51","author":"Skeie","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2008.06.035","article-title":"Age-related macular degeneration and complement activation-related diseases: a population-based case-control study","volume":"115","author":"Nitsch","year":"2008","journal-title":"Ophthalmology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"483960","DOI":"10.1155\/2014\/483960","article-title":"Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue","volume":"2014","author":"Kawa","year":"2014","journal-title":"J Immunol Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2199","DOI":"10.1371\/journal.pone.0002199","article-title":"C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes","volume":"3","author":"Jakobsdottir","year":"2008","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000356513","article-title":"The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?","volume":"6","author":"Langford-Smith","year":"2014","journal-title":"J Innate Immun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/eji.200323541","article-title":"A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein","volume":"33","author":"Giannakis","year":"2003","journal-title":"Eur J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1074\/jbc.M109.044529","article-title":"Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations","volume":"285","author":"Okemefuna","year":"2010","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature10449","article-title":"Complement factor H binds malondialdehyde epitopes and protects from oxidative stress","volume":"478","author":"Weismann","year":"2011","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.4049\/jimmunol.1401613","article-title":"Identification of factor H-like protein 1 as the predominant complement regulator in Bruch\u2019s membrane: implications for age-related macular degeneration","volume":"193","author":"Clark","year":"2014","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"30192","DOI":"10.1074\/jbc.M110.103986","article-title":"Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch\u2019s membrane in human retina","volume":"285","author":"Clark","year":"2010","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive protein","volume":"279","author":"Black","year":"2004","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","article-title":"The physiological structure of human C-reactive protein and its complex with phosphocholine","volume":"7","author":"Thompson","year":"1999","journal-title":"Structure"},{"key":"B55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3181\/00379727-136-35323","article-title":"Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide","volume":"136","author":"Volanakis","year":"1971","journal-title":"Proc Soc Exp Biol Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/281155a0","article-title":"Interaction of C-reactive protein with artificial phosphatidylcholine bilayers","volume":"281","author":"Volanakis","year":"1979","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1074\/jbc.M115.702746","article-title":"The carbohydrate-linked phosphorylcholine of the parasitic nematode product ES-62 modulates complement activation","volume":"291","author":"Ahmed","year":"2016","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1096\/fj.06-6722com","article-title":"Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m)","volume":"21","author":"Ji","year":"2007","journal-title":"FASEB J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.4049\/jimmunol.1002488","article-title":"Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant","volume":"187","author":"Lauer","year":"2011","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.113.007124","article-title":"Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy","volume":"130","author":"Thiele","year":"2014","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"40775","DOI":"10.1074\/jbc.M205378200","article-title":"Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils","volume":"277","author":"Khreiss","year":"2002","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/01.CIR.0000125527.41598.68","article-title":"Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells","volume":"109","author":"Khreiss","year":"2004","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/01.RES.0000183881.11739.CB","article-title":"Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils","volume":"97","author":"Khreiss","year":"2005","journal-title":"Circ Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr226","article-title":"Monomeric CRP is prothrombotic and dissociates from circulating pentameric CRP on adhered activated platelets under flow","author":"Molins","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/ATVBAHA.108.174359","article-title":"C-reactive protein isoforms differ in their effects on thrombus growth","volume":"28","author":"Molins","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1038\/ncomms14188","article-title":"Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites","volume":"8","author":"Braig","year":"2017","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1074\/jbc.M116.773176","article-title":"Functional transformation of C-reactive protein by hydrogen peroxide","volume":"292","author":"Singh","year":"2017","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/cvr\/cvs237","article-title":"Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction","volume":"96","author":"Habersberger","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s41048-015-0003-2","article-title":"Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification","volume":"1","author":"Potempa","year":"2015","journal-title":"Biophys Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ab.2009.04.037","article-title":"Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor","volume":"391","author":"Christopeit","year":"2009","journal-title":"Anal Biochem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jmr.1090","article-title":"Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component","volume":"24","author":"Mikolajek","year":"2011","journal-title":"J Mol Recognit"},{"key":"B74","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.preteyeres.2009.08.001","article-title":"Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins","volume":"28","author":"Curcio","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/archopht.123.3.321","article-title":"The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.nut.2005.12.004","article-title":"C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration","volume":"22","author":"Seddon","year":"2006","journal-title":"Nutrition"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/bjo.2005.067397","article-title":"The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study","volume":"89","author":"McGwin","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ophtha.2009.11.020","article-title":"C-reactive protein and CFH, ARMS2\/HTRA1 gene variants are independently associated with risk of macular degeneration","volume":"117","author":"Seddon","year":"2010","journal-title":"Ophthalmology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/jamaophthalmol.2017.2191","article-title":"Association of C-reactive protein genetic polymorphisms with late age-related macular degeneration","volume":"135","author":"Cipriani","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1167\/iovs.15-17009","article-title":"Assessment of proteins associated with complement activation and inflammation in maculae of human donors homozygous risk at chromosome 1 CFH-to-F13B","volume":"56","author":"Keenan","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e93459","DOI":"10.1371\/journal.pone.0093459","article-title":"Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels","volume":"9","author":"Ristau","year":"2014","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/ddp472","article-title":"Genetic control of the alternative pathway of complement in humans and age-related macular degeneration","volume":"19","author":"Hecker","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.178.6.3831","article-title":"Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein","volume":"178","author":"Laine","year":"2007","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/bjo.2010.199216","article-title":"C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration","volume":"95","author":"Bhutto","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2007.02535.x","article-title":"Studies on the interactions between C-reactive protein and complement proteins","volume":"121","author":"B\u00edr\u00f3","year":"2007","journal-title":"Immunology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"30451","DOI":"10.1074\/jbc.M803648200","article-title":"Complement factor H binds to denatured rather than to native pentameric C-reactive protein","volume":"283","author":"Hakobyan","year":"2008","journal-title":"J Biol Chem"},{"key":"B89","doi-asserted-by":"publisher","first-page":"C244","DOI":"10.1152\/ajpcell.00057.2016","article-title":"C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function","volume":"312","author":"Molins","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"22889","DOI":"10.1038\/srep22889","article-title":"Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants","volume":"6","author":"Molins","year":"2016","journal-title":"Sci Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/path.4766","article-title":"Monomeric C-reactive protein and inflammation in age-related macular degeneration","volume":"240","author":"Chirco","year":"2016","journal-title":"J Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T04:12:00Z","timestamp":1524111120000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2018.00808"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00808","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]},"article-number":"808"}}